Geode Capital Management LLC Has $215.79 Million Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Geode Capital Management LLC grew its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 1.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,483,184 shares of the company's stock after purchasing an additional 53,554 shares during the quarter. Geode Capital Management LLC owned approximately 1.72% of DocuSign worth $215,789,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Itau Unibanco Holding S.A. bought a new position in DocuSign during the 3rd quarter worth approximately $28,000. Brooklyn Investment Group acquired a new position in shares of DocuSign in the 3rd quarter valued at about $33,000. Reston Wealth Management LLC bought a new stake in shares of DocuSign during the 3rd quarter valued at about $47,000. nVerses Capital LLC acquired a new position in DocuSign in the second quarter valued at approximately $48,000. Finally, Quarry LP bought a new position in shares of DocuSign during the second quarter valued at approximately $53,000. Institutional investors own 77.64% of the company's stock.

DocuSign Price Performance

Shares of DocuSign stock traded down $0.04 on Friday, hitting $94.48. The company had a trading volume of 2,691,817 shares, compared to its average volume of 2,985,802. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company has a market cap of $19.09 billion, a PE ratio of 19.48, a PEG ratio of 8.72 and a beta of 0.92. The business has a 50-day simple moving average of $78.04 and a 200-day simple moving average of $63.41.

Insiders Place Their Bets

In other news, insider Robert Chatwani sold 14,799 shares of the stock in a transaction on Wednesday, September 18th. The stock was sold at an average price of $55.46, for a total transaction of $820,752.54. Following the completion of the sale, the insider now owns 70,748 shares in the company, valued at approximately $3,923,684.08. This represents a 17.30 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Daniel D. Springer sold 581,588 shares of DocuSign stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the completion of the transaction, the director now owns 906,430 shares in the company, valued at $87,959,967.20. The trade was a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 651,184 shares of company stock worth $60,878,829 over the last ninety days. Company insiders own 1.66% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Hsbc Global Res raised DocuSign to a "moderate sell" rating in a report on Friday, December 6th. HSBC reiterated a "reduce" rating on shares of DocuSign in a research note on Friday, December 6th. Piper Sandler upped their price target on shares of DocuSign from $60.00 to $90.00 and gave the stock a "neutral" rating in a research report on Friday, December 6th. Morgan Stanley increased their price objective on shares of DocuSign from $62.00 to $97.00 and gave the stock an "equal weight" rating in a report on Friday, December 6th. Finally, Wells Fargo & Company boosted their target price on shares of DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a research note on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.